Diallyl Trisulfide: A potent antiviral against H9N2 Influenza
Shayan Ahmed, Jamia Millia Islamia, New Delhi Influenza is a serious respiratory infection that causes a significant amount of morbidity and mortality. Annually, it is estimated that 290,000–650,000 people die from influenza. There are currently two kinds of anti-influenza virus therapeutic options: M2 channel blockers and neuraminidase inhibitors. However, the clinical utility of these medicines […]
